Skip to main content

Table 3 Summary of the results

From: Expression of the Tpl2/Cot oncogene in human T-cell neoplasias

Patient no. Immunophenotype Serum TNF-α (pg/ml) Tpl2/Cot (fold increase)
1 CD3+, CD4+, CD7- 1.7 0.6
2 CD3+, CD8+, CD56+, CD57+, TCRαβ+ 1.9 3.9
3 CD3+, CD8+, CD16, 56-, CD57+, TCRαβ+ 1.8 4
4 CD3+, CD4+, CD5+, CD7+ 1.5 0.7
5 CD3+, CD4+, CD7- 1.9 1.2
6 TdT+, CD5+, CD2+ 2.5 1.7
7 CD3+CD4+CD25-TCRγ+ 3.8 1.8
8 CD2+, CD3-, CD16+, CD56-, CD57-, TCR- 6.2 5.2
9 TdT+, CD2+, CD3+, CD7+, CD4-, CD8- 2.6 0.3
10 2 populations: a) T-LGL CD3+, CD8+, CD56+, CD57+, TCR γ+ b) NK CD2+, CD3-, CD16, 56+, 57- 1.9 5
11 CD3+, CD4+, CD7-, CD25-, TCRαβ+ 1.2 1.1
12 TdT+, cCD3+, CD7+, CD4-CD8- 1.5 1.2